KIMIA FARMA -B-
PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and markets chemical, betalactam and non betalactam, antiretr… Read more
Market Cap & Net Worth: KIMIA FARMA -B- (HQP)
KIMIA FARMA -B- (MU:HQP) has a market capitalization of $787.88 Million (€767.56 Million) as of March 18, 2026. Listed on the MU stock exchange, this Germany-based company holds position #19229 globally and #2042 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying KIMIA FARMA -B-'s stock price €0.14 by its total outstanding shares 5553999872 (5.55 Billion).
KIMIA FARMA -B- Market Cap History: 2015 to 2025
KIMIA FARMA -B-'s market capitalization history from 2015 to 2025. Data shows change from $273.65 Million to $787.88 Million (-78.73% CAGR).
KIMIA FARMA -B- Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how KIMIA FARMA -B-'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
KIMIA FARMA -B-'s market cap is 0.00 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.01 Billion | $5.81 Trillion | $267.41 Billion | 0.00x | 0.00x |
| 2017 | $5701.03 Trillion | $6.13 Trillion | $326.79 Billion | 930.40x | 17445.74x |
| 2018 | $5701.03 Trillion | $7.45 Trillion | $415.90 Billion | 764.82x | 13707.83x |
| 2019 | $346.98 Billion | $9.40 Trillion | -$12.72 Billion | 0.04x | N/A |
| 2020 | $1.20 Trillion | $10.01 Trillion | $17.64 Billion | 0.12x | 68.31x |
| 2021 | $753.02 Billion | $12.86 Trillion | $302.27 Billion | 0.06x | 2.49x |
| 2022 | $787.88 Million | $9.23 Trillion | -$190.47 Billion | 0.00x | N/A |
| 2023 | $787.88 Million | $9.87 Trillion | -$1.96 Trillion | 0.00x | N/A |
| 2024 | $787.88 Million | $9.94 Trillion | -$842.27 Billion | 0.00x | N/A |
Competitor Companies of HQP by Market Capitalization
Companies near KIMIA FARMA -B- in the global market cap rankings as of March 18, 2026.
Key companies related to KIMIA FARMA -B- by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #164 globally with a market cap of $115.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | McKesson Corporation | NYSE:MCK | $115.38 Billion | $943.25 |
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
KIMIA FARMA -B- Historical Marketcap From 2015 to 2025
Between 2015 and today, KIMIA FARMA -B-'s market cap moved from $273.65 Million to $ 787.88 Million, with a yearly change of -78.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €787.88 Million | 0.00% |
| 2024 | €787.88 Million | 0.00% |
| 2023 | €787.88 Million | 0.00% |
| 2022 | €787.88 Million | -99.90% |
| 2021 | €753.02 Billion | -37.51% |
| 2020 | €1.20 Trillion | +247.26% |
| 2019 | €346.98 Billion | -99.99% |
| 2018 | €5701.03 Trillion | 0.00% |
| 2017 | €5701.03 Trillion | +564971651.36% |
| 2016 | €1.01 Billion | +268.75% |
| 2015 | €273.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of KIMIA FARMA -B- was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $787.88 Million USD |
| MoneyControl | $787.88 Million USD |
| MarketWatch | $787.88 Million USD |
| marketcap.company | $787.88 Million USD |
| Reuters | $787.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.